Neuropharmacological analysis of agonistic actions of cyclazocine in rabbits.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001392:Azocines / Q000494:pharmacology*; D003496:Cyclazocine / Q000494:pharmacology; D004357:Drug Synergism; D004361:Drug Tolerance; D004569:Electroencephalography; D005260:Female; D003932:Heroin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology; D008722:Methods; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects* / Q000502:physiology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010423:Pentazocine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D013268:Stimulation, Chemical
D000700:Analgesics; D001392:Azocines; D009292:Narcotic Antagonists; D008694:Methamphetamine; D003932:Heroin; D009020:Morphine; D010830:Physostigmine; D012601:Scopolamine; D003496:Cyclazocine; D007099:Imipramine; D010423:Pentazocine